Ocugen, Inc. (OCGN)
1.60
+0.01
(+0.63%)
USD |
NASDAQ |
Feb 20, 16:00
1.61
+0.01
(+0.62%)
Pre-Market: 20:00
Ocugen SG&A Expense (Quarterly) : 8.228M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 36.64M |
| MannKind Corp. | 58.18M |
| Verastem, Inc. | 21.01M |
| Anavex Life Sciences Corp. | 2.126M |
| AnaptysBio, Inc. | 10.21M |